logo
搜索
菜单

Inhibition的搜索结果

当前1/3页
排序: 今日浏览数
16.15: Ribosome Profiling 02:24 min
16.15: Ribosome Profiling
14.6: Circadian Rhythms and Gene Regulation 02:19 min
14.6: Circadian Rhythms and Gene Regulation
Patch-clamp Capacitance Measurements and Ca2+ Imaging at Single Nerve Terminals in Retinal Slices 10.3791/3345-v 09:16 min
Patch-clamp Capacitance Measurements and Ca2+ Imaging at Single Nerve Terminals in Retinal Slices
5.14: Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs 01:21 min
5.14: Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
GABA-activated Single-channel and Tonic Currents in Rat Brain Slices 10.3791/2858-v
GABA-activated Single-channel and Tonic Currents in Rat Brain Slices
A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor 10.3791/2742-v 07:45 min
A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses 10.3791/2498-v
Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
21.7: Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents 01:20 min
21.7: Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
21.4: Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists 01:28 min
21.4: Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
19.5: Antiasthma Drugs: Muscarinic Receptor Antagonists 01:20 min
19.5: Antiasthma Drugs: Muscarinic Receptor Antagonists
15.3: Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs 01:28 min
15.3: Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
10.12: Heart Failure Drugs: β-Blockers 01:22 min
10.12: Heart Failure Drugs: β-Blockers
19.9: Parasympathetic Signaling 01:30 min
19.9: Parasympathetic Signaling
7.4: Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions 01:27 min
7.4: Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
6.17: Drugs Affecting Neurotransmitter Release or Uptake 01:21 min
6.17: Drugs Affecting Neurotransmitter Release or Uptake
6.15: Adrenergic Antagonists: ɑ and β-Receptor Blockers 01:31 min
6.15: Adrenergic Antagonists: ɑ and β-Receptor Blockers
3.9: Time Course of Drug Effect 01:14 min
3.9: Time Course of Drug Effect
2.5: Toxic Reactions: Overview 01:26 min
2.5: Toxic Reactions: Overview
34.5: Inhibition of CDK Activity 02:34 min
34.5: Inhibition of CDK Activity
12.26: Aldehydes and Ketones with Amines: Enamine Formation Mechanism 01:14 min
12.26: Aldehydes and Ketones with Amines: Enamine Formation Mechanism
返回顶部